Incidence, prevalence and costs of treating genital warts in the pre-HPV vaccine era in Germany, 2005

被引：4
|
作者：
Gieseking, F
Petry, KU
Hillemanns, P
Germé, M
Littlewood, KJ
Bénard, S
Breugelmans, JG
机构：
[1] Univ Klinikum Hamburg, Hamburg, Germany
[2] Klinikum Stadt Wolfsburg, Frauenklin, Wolfsburg, Germany
[3] Univ Jena, Klin Frauenheilkunde & Geburtshilfe, D-6900 Jena, Germany
[4] Mapi Values, Houten, Netherlands
[5] Sanofi Pasteur MSD, Lyon, France
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67338-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A64 / A65
页数：2
相关论文
共 13 条
  • [1] Recurrence of genitals warts in pre-HPV vaccine era after laser treatment
    Andreas Widschwendter
    Bettina Böttcher
    David Riedl
    Serab Coban
    Irene Mutz-Dehbalaie
    Raffaella Matteucci Gothe
    Alexandra Ciresa-König
    Christian Marth
    Siegfried Fessler
    Archives of Gynecology and Obstetrics, 2019, 300 : 661 - 668
  • [2] Recurrence of genitals warts in pre-HPV vaccine era after laser treatment
    Widschwendter, Andreas
    Boettcher, Bettina
    Riedl, David
    Coban, Serab
    Mutz-Dehbalaie, Irene
    Gothe, Raffaella Matteucci
    Ciresa-Koenig, Alexandra
    Marth, Christian
    Fessler, Siegfried
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2019, 300 (03) : 661 - 668
  • [3] Resource use and costs associated with the management of Pap III, Pap IIID and Pap IV in the pre-HPV vaccine era in Germany
    Petry, KU
    Hillemanns, P
    Germé, M
    Littlewood, KJ
    Bernard, S
    Breugelmans, JG
    VALUE IN HEALTH, 2005, 8 (06) : A64 - A64
  • [4] HPV (HUMAN PAPILLOMAVIRUS) GENOTYPE PREVALENCE IN AUSTRALIAN WOMEN PRE-HPV VACCINE ROLLOUT
    Garland, Suzanne
    Brotherton, Julia
    Condon, John
    Tabrizi, Sepehr
    McIntyre, Peter
    Smith, David
    SEXUAL HEALTH, 2008, 5 (04) : 399 - 399
  • [5] THE PREVALENCE OF HPV GENOTYPES IN PATIENTS WITH GENITAL WARTS IN SINGAPORE - WILL THE HPV VACCINE BE USEFUL IN THIS POPULATION?
    Yew, Y.
    Sen, P.
    Chio, T.
    Koay, E.
    Chan, R.
    SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 : A231 - A232
  • [6] Estimated annual number of Pap III and Pap IV patients and associated resource use in the pre-HPV vaccine era in Germany
    Petry, K. U.
    Hillemanns, P.
    Germe, M.
    Littlewood, K. J.
    Benard, S.
    Breugelmans, J. G.
    EJC SUPPLEMENTS, 2005, 3 (02): : 271 - 271
  • [7] 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV
    Pitisuttithum, Punnee
    Velicer, Christine
    Luxembourg, Alain
    EXPERT REVIEW OF VACCINES, 2015, 14 (11) : 1405 - 1419
  • [8] Incidence of human papillomavirus (HPV)-related head and neck cancers in the US from 1998-2003: Pre-HPV vaccine licensure
    Saraiya, M.
    Kawaoka, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden
    Herweijer, Eva
    Ploner, Alexander
    Sparen, Par
    VACCINE, 2018, 36 (15) : 1917 - 1920
  • [10] Estimated incidence and transmission intensity of rubella infection in Zambia pre-vaccine era 2005-2016
    Mazaba, Mazyanga L.
    Bosomprah, Samuel
    Cohen, Daniel
    Monze, Mwaka
    Siziya, Seter
    EPIDEMIOLOGY & INFECTION, 2022, 151
12